REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.00
Bid: 121.20
Ask: 122.00
Change: 1.60 (1.33%)
Spread: 0.80 (0.66%)
Open: 121.00
High: 122.00
Low: 120.40
Prev. Close: 120.40
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: BATM signs new deal; Synectics wins two projects

Wed, 03rd Nov 2021 14:38

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

BATM Advanced Communications Ltd - Israel-based data and telecommunication products provider - Says its Edgility virtual networking solution has been selected by e-Qual, a managed service provider based in France, for the management and orchestration of its service provision to its enterprise customers globally. The contract has a minimum period of five years.

----------

Synectics PLC - Sheffield-based security systems services company - Secures two major new casino projects in North America. Working with local integration partner, Zuvid Surveillance Systems, Synectics says it will provide new surveillance management systems based on its Synergy software platform for Fallsview Casino Resort in Canada. Delivery will commence before the end of 2021, with a five-year support contract already agreed, following completion in early 2022.

----------

Syncona Ltd - London-based investment trust focussed on healthcare - Commits USD30.0 million to Clade Therapeutics in a USD87 million series A financing. Syncona's holding value in Clade is GBP11.2 million following the investment of the first tranche of the series A commitment and, at the point all current commitments are invested, Syncona will have 23% stake in the business.

----------

SulNOx Group PLC - London-based supplier of fuel additives - Confirms that the US unit of Bureau Veritas, a provider of testing, inspection, and certification services, has certified that both US automotive gasoline/petrol and US diesel fuel with SulNOx's SulnoxEco fuel conditioner added at the recommended levels, continues to comply with the US ASTM specifications.

----------

Fox Marble Holdings PLC - London-based quarrying, stone processing and dimension stone marketing company - Signs a joint venture agreement with Al Bab Al Mumtaz Group in the United Arab Emirates. Under the agreement, it is anticipated that Fox Marble will supply Al Bab Al Mumtaz Group with marble tiles and slabs processed in its factory in Kosovo, for sale via its range of outlets in the region. The arrangement is expected to generate revenue in the region of AED2 million, about GBP399,147, in its first year of operation of 2022 and AED4 million in 2023.

----------

Empire Metals Ltd - London-based exploration and resource development company - Reports the results of the recently completed reverse circulation drilling programme at the Central Menzies gold project in western Australia, over which it holds an option to acquire a 75% interest. The company says 2,379 metres of drilling has been completed, focusing on the two mineralised trends known as Teglio and Nugget Patch. "Current thinking is that we have encountered a supergene enrichment zone and that a higher-grade target may persist beneath and further to the southwest. This find certainly warrants additional drilling to determine if a higher-grade mineralised lode follows this near surface trend," says Managing Director Shaun Bunn.

----------

Mkango Resources Ltd - Vancouver, Canada-based mineral exploration and development company - Increases its interest in HyProMag to almost 42% from 25%. This follows the exercise by HyProMag of its right to convert into shares the GBP200,000 loan which formed part of the GBP500,000 financing package completed in January 2020.

----------

Empyrean Energy PLC - Australian oil & gas explorer and producer - Makes operational progress towards spudding the LH 17-2-1 exploration well at the Jade prospect on block 29/11, offshore China in December. In the event of a commercial discovery, Empyrean's partner, CNOOC, has a back in right to a 51% participating interest in the development and production phase.

----------

Caracal Gold PLC - London-based mining company - Completes the connection to Kenya's national grid power operations at its producing Kilimapesa gold mining & processing operations in Kenya. "As well as providing major cost savings to our gold mining operations, the switch to the national grid delivers significant associated environmental benefits given Kenya's use of renewable energy, most of which comes from geothermal, hydro, and wind," says Chief Executive Robbie McCrae.

----------

Mosman Oil & Gas Ltd - New South Wales, Australia-based exploration, development and production company - Says Stanley-5 well in Polk County, East Texas, has been drilled to the target depth, logged and cased. Several Yegua sands from 4,200-4,800 feet have been identified as oil bearing from logs and sidewall cores. "This fifth successful well at Stanley is the next step to building on our delivery against the strategic objective to increase production," says Chair John Barr.

----------

Asiamet Resources Ltd - White Rock, Canada-based exploration and development company - Says PT Delta Dunia Makmur Tbk, an Indonesian mining services company, will earn a 51% interest Asiamet's wholly-owned subsidiary Indokal Ltd by contributing USD50 million towards the BKM copper mine development, located in Kalimantan, Indonesia. "We are confident PT Delta Dunia as a strategic partner brings the necessary technical, commercial capability and experience to support Asiamet in meeting its objectives for the development of both the BKM copper project and its broader business," says Asiamet Executive Chair Tony Manini.

----------

Kodal Minerals PLC - London-based lithium focussed development and exploration company - Buys the minority shareholdings from vendors of Bougouni project. These acquisition results in Kodal having 100% interest in all concessions of the Bougouni lithium project with the concessions all held in the name of Kodal's Malian subsidiary companies. Kodal says each vendor will receive a cash payment of USD600,000 and a net smelter return royalty for production attributed to each vendor's relevant concessions of 0.6%. The acquisition of the minority interests allows the Company to further explore development and financing opportunities as the 100% owner, it says.

----------

Altus Strategies PLC - Didcot, England-based mining royalty company - Reports the intersection of high grades from diamond drilling at Diba gold project in western Mali. "A near-surface intersection of 21.9 grams per tonne over 10.2 metres represents an outstanding start to the current drilling campaign at Diba," says Chief Executive Steven Poulton. "We look forward to updating shareholders on the results of this programme when they are received."

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
11 Apr 2024 14:22

Syncona agrees to sell stake in investee company for GBP7.4 million

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Therapeutics Inc.

Read more
4 Apr 2024 17:06

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million in 2023 from USD71.1 million in 2022. General and administrative costs contract by 19% to USD17.0 million from USD21.1 million. According to Syncona's website, the company has a 25% stake in Achilles.

Read more
14 Mar 2024 14:16

Syncona portfolio company Autolus posts widened loss for 2023

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses.

Read more
12 Feb 2024 18:01

IN BRIEF: Freeline shareholders approve Syncona acquisition

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona.

Read more
8 Feb 2024 13:45

UPDATE: Syncona portfolio strengthens thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes.

Read more
8 Feb 2024 09:41

Syncona portfolio strengthens in third quarter thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday reported a recent increase to the value of its portfolio, as the company said it was in a strong position to push forward its main life science companies.

Read more
8 Feb 2024 09:04

Syncona NAV grows in Q3

(Sharecast News) - Life sciences investor Syncona said on Thursday that its net asset value had grown in the three months ended 31 December, driven by a prioritisation of capital allocation across its portfolio to enable the delivery of key inflection points.

Read more
22 Jan 2024 12:19

IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with relapsed/refractory adult B-cell acute lymphoblastic leukaemia. The FDA has set a target action date of November 16 for reviewing the application, Syncona says. Further, Autolus is on track to submit a marketing authorisation application to the EU's European Medicines Agency in the first half of 2024.

Read more
19 Jan 2024 08:36

Syncona says Freeline trial for Gaucher disease treatment positive

(Alliance News) - Syncona Ltd on Friday noted Freeline Therapeutics Holdings PLC's positive data for Gaucher disease treatment.

Read more
4 Dec 2023 09:37

IN BRIEF: Syncona notes Beacon's "encouraging" AGTC-501 trial data

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company, Beacon Therapeutics has presented three-month data from the phase 2 Skyline trial of its viral vector-based gene therapy AGTC-501 in X-linked retinitis pigmentosa at the Floretina ICOOR 2023 Congress in Rome. Notes AGTC-501 shows an "encouraging efficacy profile", showing a "significant improvement" in retinal sensitivity. Adds that there are no clinically significant safety events related to AGTC-501.

Read more
27 Nov 2023 19:03

TRADING UPDATES: Molten Ventures completes raise; Saietta proposes one

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Nov 2023 14:30

IN BRIEF: Syncona agrees to buyout deal with Freeline Therapeutics

Syncona Ltd - London-based investor in healthcare companies - Agrees to acquire all remaining stock in investee Freeline Therapeutics Holdings PLC for USD6.50 in cash per share, valuing Freeline at approximately USD28.3 million. Syncona currently owns 49.7% of shares in Freeline. The company will provide up to USD15 million of financing in conjunction with the acquisition to enable Freeline to meet its near-term cash requirements and continue advancing its lead programme FLT201, a potential gene therapy for Gaucher disease.

Read more
16 Nov 2023 10:34

Syncona reports declining asset value as investment head steps down

(Alliance News) - Syncona Ltd on Thursday said net asset value decreased as it swung to a negative return in its latest half year, but that it is well-positioned for future growth thanks to its "rich pipeline".

Read more
16 Nov 2023 08:44

Syncona net asset value falls, co-founder steps down

(Sharecast News) - Life science specialist Syncona reported a net asset value of £1.2bn at the end of its first half on Thursday, down from £1.25bn on 31 March, with a net asset value return of -4.2% during the period.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.